Search by Drug Name or NDC
NDC 00069-5800-61 Tikosyn 0.125 mg/1 Details
Tikosyn 0.125 mg/1
Tikosyn is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Pfizer Laboratories Div Pfizer Inc. The primary component is DOFETILIDE.
MedlinePlus Drug Summary
Dofetilide is used to treat an irregular heartbeat (including atrial fibrillation or atrial flutter). It is in a class of medications called antiarrhythmics. It improves your heart rhythm by relaxing an overactive heart.
Related Packages: 00069-5800-61Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dofetilide
Product Information
| NDC | 00069-5800 |
|---|---|
| Product ID | 0069-5800_a4df6111-f3d6-48d1-84d9-a7d4ee3175a3 |
| Associated GPIs | 35400025000110 |
| GCN Sequence Number | 044360 |
| GCN Sequence Number Description | dofetilide CAPSULE 125 MCG ORAL |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 92287 |
| HICL Sequence Number | 020864 |
| HICL Sequence Number Description | DOFETILIDE |
| Brand/Generic | Brand |
| Proprietary Name | Tikosyn |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | dofetilide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 0.125 |
| Active Ingredient Units | mg/1 |
| Substance Name | DOFETILIDE |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc |
| Pharmaceutical Class | Antiarrhythmic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020931 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00069-5800-61 (00069580061)
| NDC Package Code | 0069-5800-61 |
|---|---|
| Billing NDC | 00069580061 |
| Package | 14 CAPSULE in 1 BOTTLE (0069-5800-61) |
| Marketing Start Date | 1999-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |